Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
Acta Paediatrica (Oslo, Norway : 1992)|February 3, 2015
The incidence of type 1 diabetes is still increasing in the Netherlands, but has stabilised in children under five (Young DUDEs-1)Engelina A J M Spaans, Lisette M A Gusdorf, Klaas H Groenier, et al.
Diabetes, Obesity & Metabolism|June 7, 2016
Addition of sulphonylurea to metformin does not relevantly change body weight: a prospective observational cohort study (ZODIAC-39)Dennis Schrijnders, Raiza Wever, Nanne Kleefstra, et al.
JAMA Internal Medicine|September 16, 2014
Efficacy of device-guided breathing for hypertension in blinded, randomized, active-controlled trials: a meta-analysis of individual patient dataGijs W D Landman, Kornelis J J van Hateren, Peter R van Dijk, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|September 5, 2015
After 6years of intraperitoneal insulin administration IGF-I concentrations in T1DM patients are at low-normal levelPeter R van Dijk, Susan J J Logtenberg, Simona I Chisalita, et al.
BMC Health Services Research|October 4, 2015
Validation of the howRu and howRwe questionnaires at the individual patient levelSteven H Hendriks, Jojanneke Rutgers, Peter R van Dijk, et al.
BMC Cancer|June 25, 2017
Within-class differences in cancer risk for sulfonylurea treatments in patients with type 2 diabetes (ZODIAC-55) - a study protocolDennis Schrijnders, Geertruida H de Bock, Sebastiaan T Houweling, et al.
The Journal of Clinical Endocrinology and Metabolism|April 27, 2016
Different Effects of Intraperitoneal and Subcutaneous Insulin Administration on the GH-IGF-1 Axis in Type 1 DiabetesPeter R van Dijk, Susan J J Logtenberg, Simona I Chisalita, et al.
JAMA Internal Medicine|June 12, 2013
Device-guided breathing as treatment for hypertension in type 2 diabetes mellitus: a randomized, double-blind, sham-controlled trialGijs W D Landman, Iefke Drion, Kornelis J J van Hateren, et al.
Plos One|July 14, 2012
Effect of benfotiamine on advanced glycation endproducts and markers of endothelial dysfunction and inflammation in diabetic nephropathyAlaa Alkhalaf, Nanne Kleefstra, Klaas H Groenier, et al.
Plos One|March 17, 2015
Comparison of methods for renal risk prediction in patients with type 2 diabetes (ZODIAC-36)Ineke J Riphagen, Nanne Kleefstra, Iefke Drion, et al.
Pageof 12